Detrimental role for CD4+ T lymphocytes in murine diffuse peritonitis due to inhibition of local bacterial elimination

Gut

Volumn 57, Issue 2, 2008, Pages 188-195

  Busse, M ^a   Traeger, T ^a   Potschke C ^a   Billing, A ^a   Dummer, A ^a   Friebe, E ^a   Kiank, C ^a   Grunwald, U ^a   Jack, R S ^a   Schutt C ^a   Heidecke, C D ^a   Maier, S ^a   Broker B M ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; MONOCLONAL ANTIBODY; T LYMPHOCYTE RECEPTOR; TACROLIMUS; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN RECOGNITION; APOPTOSIS; ARTICLE; BACTERIUM COLONY; CD4+ T LYMPHOCYTE; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GRANULOCYTE; INNATE IMMUNITY; MACROPHAGE; MOUSE; NONHUMAN; PERITONEAL CAVITY; PERITONITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

ABDOMEN; ANIMALS; BACTERIA; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; IMMUNOSUPPRESSIVE AGENTS; MICE; PERITONITIS; RECEPTORS, ANTIGEN, T-CELL; SEPSIS; TACROLIMUS;

EID: 38549116085     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2007.121616     Document Type: Article

References (46)

1. Angus D, Linde-Zwirble W, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-10.
2. Bosscha K, van Vroonhoven TJ, van der Werken C. Surgical management of severe secondary peritonitis. Br J Surg 1999;86:1371-7.
3. Docke WD, Randow F, Syrbe U, et al. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med 1997;3:678-81.
4. Hotchkiss R, Karl I. The pathophysiology and treatment of sepsis. N Engl J Med 2003;348:138-50.
5. Belkaid Y, Rouse BT. Natural regulatory T cells in infectious disease. Nat Immunol 2005;6:353-60.
6. Heidecke CD, Hensler T, Weighardt H, et al. Selective defects of T lymphocyte function in patients with lethal intraabdominal infection. Am J Surg 1999;178:288-92.
7. Hensler T, Hecker H, Heeg K, et al. Distinct mechanisms of immunosuppression as a conseguence of major surgery. Infect Immun 1997;65:2283-91.
8. Prass K, Meisel C, Hoflich C, et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1 -like immunostimulation. J Exp Med 2003;198:725-36.
9. Hotchkiss RS, Tinsley KW, Karl IE. Role of apoptotic cell death in sepsis. Scand J Infect Dis 2003;35:585-92.
10. Hotchkiss RS, Tinsley KW, Swanson PE, et al. Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc Natl Acad Sci USA 1999;96:14541-6.
11. Bommhardt U, Chang KC, Swanson PE, et al. Akt decreases lymphocyte apoptosis and improves survival in sepsis. J Immunol 2004;172:7583-91.
12. Jack R, Fan X, Bernheiden M, et al. Lipopolysaccharide- binding protein is required to combat a murine Gram-negative bacterial infection. Nature 1997;389:742-5.
13. Jones-Carson J, Fantuzzi G, Siegmund B, et al. Suppressor αβ T lymphocytes control innate resistance to endotoxic shock. J Infect Dis 2005;192:1039-46.
14. Wraith DC, Nicolson KS, Whitley NT. Regulatory CD4+ T cells and the control of autoimmune disease. Curr Opin Immunol 2004;16:695- 701.
15. Fontenot JD, Rudensky AY. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol 2005;6:331-7.
16. Egen JG, Kuhns MS, Allison JP. CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nat Immunol 2002;3:611-8.
17. Kroczek RA, Mages HW, Hutloff A. Emerging paradigms of T-cell co-stimulation. Curr Opin Immunol 2004;16:321-7.
18. Riley JL, June CH. The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation. Blood 2005;105:13-21.
19. Smith DW, Nagler-Anderson C. Preventing intolerance: the induction of nonresponsiveness to dietary and microbial antigens in the intestinal mucosa. J Immunol 2005;174:3851-7.
20. Macpherson AJ, Harris NL. Interactions between commensal intestinal bacteria and the immune system. Nature Rev Immunol 2004;4:478-85.
21. Cong Y, Weaver CT, Lazenby A, et al. Colitis induced by enteric bacterial antigen-specific CD4+ T cells requires CD40-CD40 ligand interactions for a sustained increase of mucosal IL-12. J Immunol 2000;165:2173-82.
22. Gad M, Pedersen AE, Kristensen NN, et al. Demonstration of strong enterobacterial reactivity for CD4+CD25- T cells from conventional and germfree mice which is counter-regulated by CD4+CD25+ T cells. Eur J Immunol 2004;34:695-704.
23. Morrissey PJ, Charrier K, Braddy S, et al. CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice: disease development is prevented by cotransfer of purified CD4+ T cells. J Exp Med 1993;178:237-44.
24. Powrie F, Correa-Oliveira R, Mauze S, et al. Regulatory interactions between CD45RBhigh and CD40RBlow CD4-T cells are important for the balance between protective and pathogenic cell-mediated immunity. J Exp Med 1994;179:589-600.
25. Singh B, Read S, Asseman C, et al. Control of intestinal inflammation by regulatory T cells. Immunol Rev 2001;182:190-200.
26. Caramalho I, Lopes-Carvalho T, Ostler D, et al. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med 2003;197:403-11.
27. Maier S, Traeger T, Entleutner M, et al. Cecal ligation and puncture versus colon ascendens stent peritonitis: two distinct animal models for polymicrobial sepsis. Shock 2004;21(6):505-11.
28. Zantl N, Uebe A, Neumann B, et al. Essential role of gamma interferon in survival of colon ascencens stent peritonitis, a novel murine model of abdominal sepsis. Infect Immun 1998;66:2300-9.
29. Entleutner M, Traeger T, Westerholt A, et al. Impact of interleukin-12, oxidative burst, and iNOS on the survival of murine fecal peritonitis. Int J Colorectal Dis 2006;21:64-70.
30. Emmanuilidis K, Weighardt H, Maier S, et al. Critical role of Kupffer cell-derived IL-10 for host defense in septic peritonitis. J Immunol 2001;167:3919-27.
31. Hotchkiss RS, Chang KC, Grayson MH, et al. Adoptive transfer of apoptotic splenocytes worsens survival, whereas adoptive transfer of necrotic splenocytes improves survival in sepsis. Proc Natl Acad Sci USA 2003;100:6724-9.
32. Brewer JA, Kanagawa O, Sleckman BP, et al. Thymocyte apoptosis induced by T cell activation is mediated by glucocorticoids in vivo. J Immunol 2002;169:1837-43.
33. Wang D, Muller N, McPherson K, et al. Glucocorticoids engage different signal transduction pathways to induce apoptosis in thymocytes and mature T cells. J Immunol 2006;176:1695-702.
34. Manjuck J, Saha DC, Astiz M, et al. Decreased response to recall antigens is associated with depressed costimulatory receptor expression in septic critically ill patients. J Lab Clin Med 2000;135:153-60.
35. Venet F, Pachot A, Debard AL, et al. Increased percentage of CD4+CD25+ regulatory T cells during septic shock is due to the decrease of CD4+CD25- lymphocytes. Crit Care Med 2004;32:2329-31.
36. Pandiyan P, Gartner D, Soezeri O, et al. CD152 (CTLA-4) determines the unequal resistance of Th1 and Th2 cells against activation-induced cell death by a mechanism requiring PI3 kinase function. J Exp Med 2004;199:831-42.
37. Chen X, Murakami T, Oppenheim JJ, et al. Differential response of murine CD4+CD25+ and CD4+CD25- T cells to dexamethasone-induced cell death. Eur J Immunol 2004;34:859-69.
38. Schlotmann T, Waase I, Jülch C, et al. CD4+ αβ-T lymphocytes express high levels of the T lymphocyte antigen CTLA-4 (CD152) in acute malaria. J Infect Dis 2000;182:367-70.
39. Yang KK, Dorner BG, Merkel U, et al. Neutrophil influx in response to a peritoneal infection with Salmonella is delayed in lipopolysaccharide-binding protein or CD14-deficient mice. J Immunol 2002;169:4475-80.
40. Kursar M, Bonhagen K, Fensterle J, et al. Regulatory CD4+CD25+ T cells restrict memory CD8+ T cell responses. J Exp Med 2002;196:1585-92.
41. Cong Y, Weaver CT, Lazenby A, et al. Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora. J Immunol 2002;169:6112-9.
42. Watanabe T, Yamori M, Kita T, et al. CD4+CD25+ T cells regulate colonic localization of CD4 T cells reactive to microbial antigen. Inflamm Bowel Dis 2005;11:541-50.
43. Xia M, Gasser J, Feige U. Dexamethasone enhances CTLA-4 expression during T cell activation. Cell Mol Life Sci 1999;55:1649-56.
44. Proft T, Fraser J. Superantigens: just like peptides, only different. J Exp Med 1998;187:819-21.
45. Maloy KJ, Salaun L, Cahill R, et al. CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 2003;197:111-9.
46. Bettelli E, Oukka M, Kuchroo V. Th-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007;8:345-50.